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Results
Synthesis of Results
81.8% of the studies advocate for the use of dexmedetomidine in 
preventing and treating POD and emergence agitation.
Purpose
The purpose of this scoping review is to examine 
intraoperative dexmedetomidine use to prevent 
postoperative delirium (POD) in the elderly (>60 years). 
Specific Aims:
• Compare the effectiveness of dexmedetomidine to 
opioids in reducing the incidence of postoperative 
delirium.
• Determine if the use of dexmedetomidine will 
decrease the occurrence of delirium in the elderly in 
the first 48 hours after surgery.
• Determine if the use of dexmedetomidine will result in 
better patient outcomes in the first 48 hours of the 
postoperative period.
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Background
Methods
• Eligibility Criteria for Articles
• Evaluates the efficacy of dexmedetomidine for prevention 
of postoperative delirium
• Published in the last 5 years (as of 2019)
• Peer-reviewed
• Published in English
• Abstract included
• Free access
• Study subjects 60 years or older
• The Search
• Database search developed with assistance of the academic 
librarian from November 1 to November 15, 2019.
• PubMed, CINAHL, PsychINFO, Google Scholar, and scanning of 
references
• Selection of Sources of Evidence
• 9,000 sources initially identified
• Each author selected 5 articles for review by co-authors
• Created annotated literature tables for easy screening
• 4 articles excluded; 11 articles included in scoping review
• Data Charting
• Developed data-charting form on Microsoft Word
• Data items extracted include author(s) of the publication, the year, 
the country of origin, the study population, sample size, 
methods/interventions, and key findings relating to the scoping 
review question
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Implications for Practice
• Using the confusion assessment method will aid in identifying 
those at risk for POD. 
• Dexmedetomidine mitigates cognitive impairment induced by 
acute pain, encouraging early ambulation and shortening 
length of stay.
• Dexmedetomidine decreases the perception of pain by 
decreasing the release of norepinephrine. Decreased pain 
leads to decreased usage of opioids.
• Further research is needed with larger sample sizes, proper 
screening of patients, and inclusion of providers willing to 
participate with the study’s plan of care. 
• Opioid-induced POD is 
a well-recognized entity 
leading to increased 
length of hospital stays, 
increased hospital 
costs, and increased 
morbidity in the elderly. 
• Dexmedetomidine is a 
potential alternative for 
opioids, as it mitigates 
cognitive dysfunction 
secondary to acute pain compared to standard 
opioid-based analgesia.  
• Dexmedetomidine is an alpha-2 agonist, 
delivering sedative and analgesic properties with 
fewer negative effects than opioids. 
• Compared to opioids, dexmedetomidine 
decreases the perception of acute pain, 
enhances chronic pain management, reduces 
the frequency of POD, and has no addictive or 
adverse effects. 
 
